Whole genome expression array profiling highlights differences in mucosal defense genes in barrett's esophagus and esophageal adenocarcinoma

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Nancarrow, Derek J ^a   Clouston, Andrew D ^b   Smithers, B Mark ^c   Gotley, David C ^c   Drew, Paul A ^d,e   Watson, David I ^e   Tyagi, Sonika ^a   Hayward, Nicholas K ^a   Whiteman, David C ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; ANTERIOR GRADIENT HOMOLOG 2 PROTEIN; CARBONATE DEHYDRATASE II; COLLAGEN; GLYCOPROTEIN; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 7; INTESTINAL TREFOIL FACTOR; KERATIN; MUCIN; MUCIN 6; PROTEIN AKR1B10; PROTEIN AKR1C2; PROTEIN ATP2A3; PROTEIN DDP4; PROTEIN PLAU; SCLEROPROTEIN; TREFOIL FACTOR 1; UNCLASSIFIED DRUG; XENOBIOTIC AGENT; MESSENGER RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER CELL; CANCER INVASION; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; EXTRACELLULAR MATRIX; GASTROESOPHAGEAL REFLUX; GENE CLUSTER; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEAVE ONE OUT CROSS VALIDATION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS; RNA EXTRACTION; SQUAMOUS EPITHELIUM; SUPPORT VECTOR MACHINE; ADENOCARCINOMA; ADOLESCENT; CASE CONTROL STUDY; CELL PROLIFERATION; COMPARATIVE STUDY; DNA MICROARRAY; ESOPHAGUS; ESOPHAGUS TUMOR; FEMALE; GENETICS; HUMAN GENOME; MALE; METABOLISM; MIDDLE AGED; MUCOSA; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

LOTUS;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPPORT VECTOR MACHINES; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79960883133     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022513     Document Type: Article

References (67)

1. Lassen A, Hallas J, de Muckadell OB, (2006) Esophagitis: incidence and risk of esophageal adenocarcinoma-a population-based cohort study. Am J Gastroenterol 101: 1193-1199.
2. Brown LM, Devesa SS, Chow WH, (2008) Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 100: 1184-1187.
3. Stavrou EP, McElroy HJ, Baker DF, Smith G, Bishop JF, (2009) Adenocarcinoma of the oesophagus: incidence and survival rates in New South Wales, 1972-2005. Med J Aust 191: 310-314.
4. Lagergren J, Mattsson F, (2010) No further increase in the incidence of esophageal adenocarcinoma in Sweden. Int J Cancer.
5. Pohl H, Sirovich B, Welch HG, (2010) Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol Biomarkers Prev 19: 1468-1470.
6. Smith KJ, O'Brien SM, Smithers BM, Gotley DC, Webb PM, et al. (2005) Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 14: 2481-2486.
7. Smith KJ, O'Brien SM, Green AC, Webb PM, Whiteman DC, (2009) Current and past smoking significantly increase risk for Barrett's esophagus. Clin Gastroenterol Hepatol 7: 840-848.
8. Cook MB, Kamangar F, Whiteman DC, Freedman ND, Gammon MD, et al. (2010) Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst 102: 1344-1353.
9. Pandeya N, Webb PM, Sadeghi S, Green AC, Whiteman DC, (2010) Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants? Gut 59: 31-38.
10. Reid BJ, Li X, Galipeau PC, Vaughan TL, (2010) Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer 10: 87-101.
11. Phillips WA, Lord RV, Nancarrow DJ, Watson DI, Whiteman DC, (2010) Barrett's Esophagus. Journal of gastroenterology and hepatology.
12. Solaymani-Dodaran M, Logan RF, West J, Card T, Coupland C, (2004) Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut 53: 1070-1074.
13. Gomes LI, Esteves GH, Carvalho AF, Cristo EB, Hirata R Jr, et al. (2005) Expression profile of malignant and nonmalignant lesions of esophagus and stomach: differential activity of functional modules related to inflammation and lipid metabolism. Cancer Res 65: 7127-7136.
14. Helm J, Enkemann SA, Coppola D, Barthel JS, Kelley ST, et al. (2005) Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma. Clin Cancer Res 11: 2478-2485.
15. Kimchi ET, Posner MC, Park JO, Darga TE, Kocherginsky M, et al. (2005) Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Cancer Res 65: 3146-3154.
16. Hao Y, Triadafilopoulos G, Sahbaie P, Young HS, Omary MB, et al. (2006) Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenterology 131: 925-933.
17. Wang S, Zhan M, Yin J, Abraham JM, Mori Y, et al. (2006) Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis. Oncogene 25: 3346-3356.
18. Greenawalt DM, Duong C, Smyth GK, Ciavarella ML, Thompson NJ, et al. (2007) Gene expression profiling of esophageal cancer: comparative analysis of Barrett's esophagus, adenocarcinoma, and squamous cell carcinoma. Int J Cancer 120: 1914-1921.
19. El-Serag HB, Nurgalieva ZZ, Mistretta TA, Finegold MJ, Souza R, et al. (2009) Gene expression in Barrett's esophagus: laser capture versus whole tissue. Scand J Gastroenterol 44: 787-795.
20. Fox CA, Sapinoso LM, Zhang H, Zhang W, McLeod HL, et al. (2005) Altered expression of TFF-1 and CES-2 in Barrett's Esophagus and associated adenocarcinomas. Neoplasia 7: 407-416.
21. Ostrowski J, Mikula M, Karczmarski J, Rubel T, Wyrwicz LS, et al. (2007) Molecular defense mechanisms of Barrett's metaplasia estimated by an integrative genomics. J Mol Med 85: 733-743.
22. Cook MB, Chow WH, Devesa SS, (2009) Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br J Cancer 101: 855-859.
23. Cook MB, Wild CP, Forman D, (2005) A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol 162: 1050-1061.
24. Nancarrow DJ, Handoko HY, Smithers BM, Gotley DC, Drew PA, et al. (2008) Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays. Cancer Res 68: 4163-4172.
25. Barbosa-Morais NL, Dunning MJ, Samarajiwa SA, Darot JF, Ritchie ME, et al. (2010) A re-annotation pipeline for Illumina BeadArrays: improving the interpretation of gene expression data. Nucleic Acids Res 38: e17.
26. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
27. Huang DW, Sherman BT, Lempicki RA, (2008) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protocols 4: 44-57.
28. Ringner M, Veerla S, Andersson S, Staaf J, Hakkinen J, (2004) ACID: a database for microarray clone information. Bioinformatics 20: 2305-2306.
29. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society 57.
30. Barrett MT, Yeung KY, Ruzzo WL, Hsu L, Blount PL, et al. (2002) Transcriptional analyses of Barrett's metaplasia and normal upper GI mucosae. Neoplasia 4: 121-128.
31. Selaru FM, Zou T, Xu Y, Shustova V, Yin J, et al. (2002) Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays. Oncogene 21: 475-478.
32. Chang Y, Gong J, Liu B, Zhang J, Dai F, (2004) Gene expression profiling in Barrett's esophagus and cardia intestinal metaplasia: a comparative analysis using cDNA microarray. World J Gastroenterol 10: 3194-3196.
33. van Baal JW, Diks SH, Wanders RJ, Rygiel AM, Milano F, et al. (2006) Comparison of kinome profiles of Barrett's esophagus with normal squamous esophagus and normal gastric cardia. Cancer Res 66: 11605-11612.
34. Stairs DB, Nakagawa H, Klein-Szanto A, Mitchell SD, Silberg DG, et al. (2008) Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus. PLoS One 3: e3534.
35. van Baal JW, Milano F, Rygiel AM, Bergman JJ, Rosmolen WD, et al. (2005) A comparative analysis by SAGE of gene expression profiles of Barrett's esophagus, normal squamous esophagus, and gastric cardia. Gastroenterology 129: 1274-1281.
36. Razvi MH, Peng D, Dar AA, Powell SM, Frierson HF Jr, et al. (2007) Transcriptional oncogenomic hot spots in Barrett's adenocarcinomas: serial analysis of gene expression. Genes Chromosomes Cancer 46: 914-928.
37. Bruford EA, Lush MJ, Wright MW, Sneddon TP, Povey S, et al. (2008) The HGNC Database in 2008: a resource for the human genome. Nucleic Acids Research 36: D445-448.
38. Fawcett T, (2003) ROC Graphs: Notes and Practical Considerations for Researchers. Tech Report HPL-2003-4, HP Laboratories.
39. Saadi A, Shannon NB, Lao-Sirieix P, O'Donovan M, Walker E, et al. (2010) Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers. Proc Natl Acad Sci U S A 107: 2177-2182.
40. Human Genome Sequencing C (2004) Finishing the euchromatic sequence of the human genome. Nature 431: 931-945.
41. Levine DS, Reid BJ, Haggitt RC, Rubin CE, Rabinovitch PS, (1989) Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium. Gastroenterology 96: 355-367.
42. Levine DS, Rubin CE, Reid BJ, Haggitt RC, (1989) Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study. Lab Invest 60: 418-432.
43. Orlando RC, (2006) Esophageal mucosal defense mechanisms. GI Motility online.
44. Christie KN, Thomson C, Xue L, Lucocq JM, Hopwood D, (1997) Carbonic anhydrase isoenzymes I, II, III, and IV are present in human esophageal epithelium. The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society 45: 35-40.
45. Dixon J, Strugala V, Griffin SM, Welfare MR, Dettmar PW, et al. (2001) Esophageal mucin: an adherent mucus gel barrier is absent in the normal esophagus but present in columnar-lined Barrett's esophagus. Am J Gastroenterol 96: 2575-2583.
46. Tobey NA, Argote CM, Vanegas XC, Barlow W, Orlando RC, (2007) Electrical parameters and ion species for active transport in human esophageal stratified squamous epithelium and Barrett's specialized columnar epithelium. Am J Physiol Gastrointest Liver Physiol 293: G264-270.
47. Ho SB, Takamura K, Anway R, Shekels LL, Toribara NW, et al. (2004) The adherent gastric mucous layer is composed of alternating layers of MUC5AC and MUC6 mucin proteins. Digestive diseases and sciences 49: 1598-1606.
48. Newton JL, Allen A, Westley BR, May FE, (2000) The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach. Gut 46: 312-320.
49. Arul GS, Moorghen M, Myerscough N, Alderson DA, Spicer RD, et al. (2000) Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study. Gut 47: 753-761.
50. Van De Bovenkamp JH, Korteland-Van Male AM, Warson C, Buller HA, Einerhand AW, et al. (2003) Gastric-type mucin and TFF-peptide expression in Barrett's oesophagus is disturbed during increased expression of MUC2. Histopathology 42: 555-565.
51. Sabo E, Meitner PA, Tavares R, Corless CL, Lauwers GY, et al. (2008) Expression analysis of Barrett's esophagus-associated high-grade dysplasia in laser capture microdissected archival tissue. Clinical cancer research: an official journal of the American Association for Cancer Research 14: 6440-6448.
52. Burjonrappa SC, Reddimasu S, Nawaz Z, Gao X, Sharma P, et al. (2007) Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus. Indian journal of cancer 44: 1-5.
53. Lefebvre O, Chenard MP, Masson R, Linares J, Dierich A, et al. (1996) Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 274: 259-262.
54. Zhang R, Niu Y, Du H, Cao X, Shi D, et al. (2009) A stable and sensitive testing system for potential carcinogens based on DNA damage-induced gene expression in human HepG2 cell. Toxicology in vitro: an international journal published in association with BIBRA 23: 158-165.
55. Li X, Galipeau PC, Sanchez CA, Blount PL, Maley CC, et al. (2008) Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression. Cancer prevention research 1: 413-423.
56. Paulson TG, Maley CC, Li X, Li H, Sanchez CA, et al. (2009) Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma. Clin Cancer Res 15: 3305-3314.
57. Wiech T, Nikolopoulos E, Weis R, Langer R, Bartholome K, et al. (2009) Genome-wide analysis of genetic alterations in Barrett's adenocarcinoma using single nucleotide polymorphism arrays. Laboratory investigation; a journal of technical methods and pathology 89: 385-397.
58. Chao DL, Sanchez CA, Galipeau PC, Blount PL, Paulson TG, et al. (2008) Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study. Clinical cancer research: an official journal of the American Association for Cancer Research 14: 6988-6995.
59. Fitzgerald RC, (2006) Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma. Gut 55: 1810-1820.
60. Vaninetti NM, Geldenhuys L, Porter GA, Risch H, Hainaut P, et al. (2008) Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. Molecular carcinogenesis 47: 275-285.
61. Doak SH, Jenkins GJ, Parry EM, Griffiths AP, Shah V, et al. (2003) Characterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma. British journal of cancer 89: 1729-1735.
62. Schneider PM, Casson AG, Levin B, Garewal HS, Hoelscher AH, et al. (1996) Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases. The Journal of thoracic and cardiovascular surgery 111: 323-331; discussion 331-323.
63. Krishnadath KK, van Blankenstein M, Tilanus HW, (1995) Prognostic value of p53 in Barrett's oesophagus. European journal of gastroenterology & hepatology 7: 81-84.
64. Galipeau PC, Prevo LJ, Sanchez CA, Longton GM, Reid BJ, (1999) Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. Journal of the National Cancer Institute 91: 2087-2095.
65. Gu J, Ajani JA, Hawk ET, Ye Y, Lee JH, et al. (2010) Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysis. Cancer prevention research 3: 1176-1186.
66. Doak SH, Jenkins GJ, Parry EM, Griffiths AP, Shah V, et al. (2003) Characterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma. Br J Cancer 89: 1729-1735.
67. Hennig EE, Mikula M, Orlowska J, Jarosz D, Bielasik A, et al. (2008) Large intra- and inter-individual variability of genes expression levels limits potential predictive value of molecular diagnosis of dysplasia in Barrett's esophagus. J Mol Med 86: 233-242.